Papers

4

Total Citations

58

H-Index

3

About

Dr. Yubo Yang is a leading figure in the advancement of minimally invasive surgical oncology, with a primary focus on robotic and laparoscopic techniques for urologic and hepatobiliary cancers. Dr. Yang’s most impactful work centers on radical cystectomy for bladder cancer, where their systematic reviews and meta-analyses have provided critical evidence comparing robot-assisted and laparoscopic approaches. Their 2020 study, cited 21 times, rigorously compared perioperative and oncologic outcomes, establishing a benchmark for surgical decision-making. Further expanding this field, Dr. Yang conducted a pooled analysis of observational studies comparing intracorporeal versus extracorporeal urinary diversion after robotic-assisted cystectomy, a work cited 19 times that directly informs best practices for post-operative recovery. Demonstrating versatility, Dr. Yang has also advanced the field of hepatobiliary surgery, with a 2024 meta-analysis on robotic versus laparoscopic liver resection for challenging posterosuperior segments (17 citations). Their most recent 2025 work explores how robotic surgery can improve safety and expand indications beyond laparoscopic limits. Through these high-impact syntheses, Dr. Yang has become a key voice in evidence-based surgical innovation, guiding the safe adoption of robotic technologies.

Research Focus

Key Achievements

3
H-Index
4
Papers
58
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of perioperative and oncologic outcomes between robot-assisted and laparoscopic radical cystectomy for bladder cancer: a systematic review and updated meta-analysis
21 citations · 2020
📈 Most Prolific Year: 2020 (2 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Sichuan University, West China Hospital of Sichuan University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago